GlassScriptPhysician profile
Raghuveer Dendi
NPI 1033137906
$52,731.56
in general payments reported to CMS, 2019-2025
32 companies · $4,641 in 2025
The $4,641 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $4,825 · 2021: $2,453 · 2022: $3,354 · 2023: $5,447 · 2024: $5,994 · 2025: $4,641.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $3,349 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500 · Entertainment: $94.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,138.18 |
| Travel and Lodging | $3,349.34 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
| Entertainment | $94.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $22,302.37 | 2019-2020 | |
| Boston Scientific Corporation | $8,562.05 | 2019-2025 | Watchman Flx, Farapulse, Watchman Access System |
| Abbott Laboratories | $5,816.02 | 2019-2025 | Amplatzer Amulet, Aveir, Ensite |
| Medtronic, INC. | $5,178.21 | 2021-2025 | Cobalt Dr Mri Surescan, Resolute Onyx, Pulseselect |
| Medtronic Vascular, INC. | $3,382.45 | 2019-2020 | |
| Biosense Webster, INC. | $2,236.06 | 2019-2025 | Nuvision Ice Catheter, Qdot Micro Catheter, Carto 3 |
| Medical Device Business Services, INC. | $1,395.81 | 2024 | Carto 3 |
| Stereotaxis INC | $1,141.63 | 2024 | Genesis |
| Biotronik INC. | $402.59 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge, Solia |
| Sanofi-Aventis U.S. LLC | $343.40 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $337.96 | 2019-2025 | Eliquis, Camzyos |
| Pfizer INC. | $277.34 | 2019-2025 | |
| Atricure, INC. | $274.64 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $143.19 | 2022-2025 | Optimizer |
| Amgen INC. | $140.33 | 2019-2025 | Repatha |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $137.37 | 2022-2024 | Verquvo |
| Cardiofocus, INC. | $113.30 | 2019 | |
| Ethicon US, LLC | $109.84 | 2022-2025 | Vistaseal, Stratafix, Surgiflo Hemostatic Matrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $83.53 | 2020-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $80.07 | 2019-2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $44.14 | 2024 | Arcalyst |
| Irhythm Technologies, INC. | $43.86 | 2024 | Zio Xt Patch, Zio Monitor, Zio At Patch |
| Philips North America LLC | $40.76 | 2023-2024 | (Am5) Lead Management |
| Astrazeneca Pharmaceuticals LP | $30.34 | 2022-2024 | |
| Scpharmaceuticals INC. | $20.19 | 2024 | |
| Alnylam Pharmaceuticals INC. | $19.42 | 2019 | |
| Novo Nordisk INC | $19.33 | 2025 | Wegovy |
| Kiniksa Pharmaceuticals, LTD. | $16.82 | 2023 | Arcalyst |
| Cardiva Medical, INC. | $13.76 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Convatec INC. | $13.47 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.31 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raghuveer Dendi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.